VRTX — VERTEX PHARMACEUTICALS

Ownership history in Broderick Brian C  ·  8 quarters on record

This page tracks every 13F SEC filing in which Broderick Brian C reported a position in VERTEX PHARMACEUTICALS (VRTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.78% (2025 Q1)
Avg. % of fund
1.17%
First filed
2024 Q1
Last filed
2025 Q4
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 17,202 -49 -0.3% 1.47% $7.8M $453.36
2025 Q3 REDUCED 17,251 -420 -2.4% 1.28% $6.8M $391.64
2025 Q2 REDUCED 17,671 -330 -1.8% 1.56% $7.9M $445.20
2025 Q1 ADDED 18,001 +1,127 +6.7% 1.78% $8.7M $484.82
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    VRTX price (monthly, adj. close)

Other funds also holding VRTX

As of 2025 Q4 — sorted by position size

Provident Investment Management, Inc. 3Y 7Y 6.16% Bellevue Group AG 3Y 7Y 5.85% Andrew Hill Investment Advisors, Inc. 3Y 4.28% Iron Triangle Partners LP 3Y 3.99% Atle Fund Management AB 3Y 7Y 3.32% MCRAE CAPITAL MANAGEMENT INC 3Y 7Y 3.29% Sofinnova Investments, Inc. 3Y 7Y 3.22% SECTORAL ASSET MANAGEMENT INC 3Y 7Y 2.91% Birch Hill Investment Advisors LLC 3Y 7Y 2.89% NIA IMPACT ADVISORS, LLC 3Y 2.68%
← Back to Broderick Brian C Holdings